Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WallStreetSelect 114
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Anika Therapeutics Inc. - Common Stock
(NQ:
ANIK
)
9.556
+0.207 (+2.21%)
Streaming Delayed Price
Updated: 1:46 PM EST, Jan 5, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Anika Therapeutics Inc. - Common Stock
< Previous
1
2
Next >
Anika (ANIK) Q3 2025 Earnings Call Transcript
↗
November 05, 2025
Anika (ANIK) Q3 2025 Earnings Call Transcript
Via
The Motley Fool
Topics
Earnings
Anika Therapeutics Inc (NASDAQ:ANIK) Reports Q3 2025 Earnings Beat and Positive Regulatory Milestone
↗
November 05, 2025
Anika Therapeutics (ANIK) beat Q3 2025 earnings estimates with a profit of $0.04 per share, driving its stock up over 10% despite a slight revenue miss.
Via
Chartmill
Topics
Earnings
Earnings Scheduled For November 5, 2025
↗
November 05, 2025
Via
Benzinga
Anika (ANIK) Q2 Revenue Beats by 4%
↗
July 31, 2025
Via
The Motley Fool
Topics
Economy
12 Health Care Stocks Moving In Wednesday's Intraday Session
↗
July 30, 2025
Via
Benzinga
Earnings Scheduled For July 30, 2025
↗
July 30, 2025
Via
Benzinga
What's Next: Anika Therapeutics's Earnings Preview
↗
October 30, 2024
Via
Benzinga
Anika Therapeutics: Q4 Earnings Insights
↗
March 13, 2024
Via
Benzinga
Earnings Outlook For Anika Therapeutics
↗
March 12, 2024
Via
Benzinga
Recap: Anika Therapeutics Q1 Earnings
↗
May 09, 2023
Via
Benzinga
ANIKA THERAPEUTICS INC (NASDAQ:ANIK) Reports Mixed Q2 2025 Results with Revenue Beat but EPS Miss, Shares Drop 9% in Pre-Market
↗
July 30, 2025
Anika Therapeutics reported mixed Q2 2025 results, with revenue beating estimates but EPS missing. Shares fell 9% amid Hyalofast trial concerns despite strong regenerative solutions growth.
Via
Chartmill
Earnings Scheduled For May 9, 2025
↗
May 09, 2025
Via
Benzinga
A Glimpse of Anika Therapeutics's Earnings Potential
↗
May 08, 2025
Via
Benzinga
Anika Therapeutics Earnings Preview
↗
March 03, 2023
Via
Benzinga
Microsoft To Rally More Than 17%? Here Are 10 Top Analyst Forecasts For Thursday
↗
March 13, 2025
Via
Benzinga
US Stocks Likely To Open Lower After A Brief Respite: 'Add Exposure To Equities' Amid Pullback, Says Expert
↗
March 13, 2025
U.S. stock futures fell again on Thursday after a brief respite on Wednesday, following a softer-than-expected inflation print.
Via
Benzinga
Topics
Economy
Why Intel Shares Are Trading Higher By Over 10%; Here Are 20 Stocks Moving Premarket
↗
March 13, 2025
Via
Benzinga
Earnings Scheduled For March 12, 2025
↗
March 12, 2025
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
↗
October 31, 2024
Via
Benzinga
ANIK Stock Earnings: Anika Therapeutics Beats EPS, Misses Revenue for Q2 2024
↗
August 08, 2024
ANIK stock results show that Anika Therapeutics beat analyst estimates for earnings per share but missed on revenue for the second quarter of 2024.
Via
InvestorPlace
Peeling Back The Layers: Exploring Anika Therapeutics Through Analyst Insights
↗
May 29, 2024
Via
Benzinga
ANIK Stock Earnings: Anika Therapeutics Beats EPS, Beats Revenue for Q1 2024
↗
May 08, 2024
ANIK stock results show that Anika Therapeutics beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.
Via
InvestorPlace
Airbnb, Blackstone Rise On News They'll Join S&P 500 Index
↗
September 02, 2023
ABNB and BX will join Sept. 18 as part of a quarterly rebalancing.
Via
Investor's Business Daily
Topics
Stocks
Earnings Scheduled For March 13, 2024
↗
March 13, 2024
Companies Reporting Before The Bell • Sangamo Therapeutics (NASDAQ:SGMO) is likely to report quarterly loss at $0.26 per share on revenue of $8.10 million.
Via
Benzinga
3 Sorry Penny Stocks to Sell in August Before It’s Too Late
↗
August 22, 2023
As interest rates rise and money becomes more expensive, investors may look to get rid of these penny stocks set to fail.
Via
InvestorPlace
Benzinga's Top Ratings Upgrades, Downgrades For August 14, 2023
↗
August 14, 2023
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For March 7, 2023
↗
March 07, 2023
Via
Benzinga
7 Stocks to Buy Before the Market Starts to Soar in 2023
↗
November 10, 2022
With the market falling into a bit of disarray, astute investors can leverage this moment to dive into compelling stocks to buy.
Via
InvestorPlace
Anika Therapeutics Cingal Tops Steroid For Osteoarthritis Pain Relief
↗
November 01, 2022
Via
Benzinga
Anika Therapeutics: Q2 Earnings Insights
↗
August 03, 2022
Anika Therapeutics (NASDAQ:ANIK) reported its Q2 earnings results on Wednesday, August 3, 2022 at 04:05 PM. Here's what investors need to know about the announcement.
Via
Benzinga
< Previous
1
2
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
